Ludvigsen, L. U. P., Andersen, A. S.
, Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P.
, Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023).
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Journal of Clinical Virology,
167, 105579. Article 105579.
https://doi.org/10.1016/j.jcv.2023.105579
Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W.
, d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023).
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica,
108(11), 3044-3057.
https://doi.org/10.3324/haematol.2023.282831
Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z.
, Bak, R. O., Holm, K.
, Sorensen, B., Nyegaard, M.
, Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023).
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Leukemia,
37(9), 1792-1801.
https://doi.org/10.1038/s41375-023-01950-9
Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C.
, Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L.
, Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023).
IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients.
International Journal of Molecular Sciences ,
24(8), Article 7314.
https://doi.org/10.3390/ijms24087314
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C.
, Lauridsen, K. L., Plesner, T. L.
, Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Antiga, E.
, Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A.
, D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023).
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology,
37(6), 1118-1134.
https://doi.org/10.1111/jdv.18931
Hybel, T. E., Vase, M. Ø.
, Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Honoré, B., Andersen, M. D., Wilken, D.
, Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B., Ebbesen, L. H.
, Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022).
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Bone Marrow Transplantation,
57(3), 460-465.
https://doi.org/10.1038/s41409-022-01567-z
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019
de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022).
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood,
140(21), 2193-2227.
https://doi.org/10.1182/blood.2022015854
Hussmann, D.
, Starnawska, A., Kristensen, L.
, Daugaard, I., Thomsen, A.
, Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J., Dalsgaard Johansen, K.
, Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G.
, Hansen, L. L. & Wojdacz, T. K. (2022).
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Haematologica,
107(4), 877-886.
https://doi.org/10.3324/haematol.2021.278477
Rosenberg, C. A., Bill, M., Maguire, O., Petersen, M. A.
, Kjeldsen, E., Hokland, P. & Ludvigsen, M. (2022).
Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
Cytometry. Part B: Clinical Cytometry,
102(2), 107-114.
https://doi.org/10.1002/cyto.b.22035
Petersen, M. A.
, Rosenberg, C. A., Brøndum, R. F.
, Aggerholm, A., Kjeldsen, E., Rahbek, O.
, Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022).
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
British Journal of Haematology,
197(4), 452-466.
https://doi.org/10.1111/bjh.18094
Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L., Vase, M.
, Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Relander, T.
, Pedersen, M. B., Ellin, F., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Holte, H., Österborg, A., Nully Brown, P. D., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Delabie, J., Sundström, C., Sander, B.
, Hamilton-Dutoit, S. J., Ehinger, M., Liestøl, K.
... d'Amore, F. A. (2022).
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial.
Blood,
140(Supplement 1), 1479–1480.
https://doi.org/10.1182
Petersen, M. A.
, Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G. ... Zelenetz, A. D. (2022).
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood,
140(11), 1229-1253.
https://doi.org/10.1182/blood.2022015851
Enemark, M. B., Hybel, T. E., Madsen, C.
, Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022).
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
Cancers,
14(5), Article 1316.
https://doi.org/10.3390/cancers14051316
Wulf, G. G., Altmann, B., Ziepert, M.
, D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F. ... ACT-2 study investigators (2021).
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Leukemia,
35(1), 143-155.
https://doi.org/10.1038/s41375-020-0838-5
Holst, J. M., Enemark, M. B., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021).
Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Case Reports in Hematology,
2021, Article 6623706.
https://doi.org/10.1155/2021/6623706
Rosenberg, C. A., Bill, M., Rodrigues, M. A., Hauerslev, M., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2021).
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Cytometry. Part B: Clinical Cytometry,
100(5), 554-567.
https://doi.org/10.1002/cyto.b.21975
Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Beck Enemark, M., Monrad, I., Madsen, C.
, Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current issues in molecular biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R.
, Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Vajavaara, H.
, Mortensen, J. B., Leivonen, S.-K.
, Hansen, I. M., Ludvigsen, M., Holte, H.
, Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021).
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma.
Cancers,
13(3), Article 398.
https://doi.org/10.3390/cancers13030398
Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021).
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
European Journal of Haematology,
107(1), 81-91.
https://doi.org/10.1111/ejh.13621
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247
Soerensen, J. F., Aggerholm, A., Kerndrup, G. B.
, Hansen, M. C., Ewald, I. K. L.
, Bill, M., Ebbesen, L. H.
, Rosenberg, C. A., Hokland, P., Ludvigsen, M. & Stidsholt Roug, A. (2020).
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Blood Advances,
4(5), 885-892.
https://doi.org/10.1182/bloodadvances.2019001157
Monrad, I., Madsen, C.
, Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020).
Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
PLOS ONE,
15(5), Article e0233449.
https://doi.org/10.1371/journal.pone.0233449
Holst, J. M., Ludvigsen, M., Hamilton-Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. & Pedersen, M. B. (2020).
High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
Hematological Oncology,
38(1), 59-66.
https://doi.org/10.1002/hon.2702
Vähämurto, P., Pollari, M., Clausen, M. R.
, D’amore, F., Leppä, S. & Mannisto, S. (2020).
Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma.
Cancers,
12(7), Article 1967.
https://doi.org/10.3390/cancers12071967
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B., Clausen, M. R.
, Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P., Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839
Clausen, M. R.
, Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S.
, Nørgaard, M. & d'Amore, F. (2020).
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Hematological Oncology,
38(3), 318-325.
https://doi.org/10.1002/hon.2734
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2020).
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
International Journal of Molecular Sciences ,
21(10), Article 3466.
https://doi.org/10.3390/ijms21103466
Madsen, C., Plesner, T. L., Bentzen, H. H. N.
, Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L.
, Ludvigsen, M. & d'Amore, F. A. (2020).
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort.
Leukemia and Lymphoma,
61(11), 2584-2594 .
https://doi.org/10.1080/10428194.2020.1779254
Lugtenburg, P. J., De Nully Brown, P., Van der Holt, B.
, D'Amore, F. A., Koene, H. R., De Jongh, E., Fijnheer, R., Van Esser, J. W., Bohmer, L. H., Pruijt, J. F., Verhoef, G. E., Hoogendoorn, M., Bilgin, M. Y., Nijland, M., Van der Burg-De Graauw, N. C., Oosterveld, M., Jie, K. S. G., Larsen, T. S., Van der Poel, M. W. ... Zijlstra-Baalbergen, J. M. (2020).
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
Journal of Clinical Oncology,
38(29), 3377-3387.
https://doi.org/10.1200/JCO.19.03418
Snipsøyr, M. G.
, Wiggers, H., Ludvigsen, M., Stensballe, A., Vorum, H.
, Poulsen, S. H., Rasmussen, L. M., Petersen, E.
& Honoré, B. (2020).
Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis.
International Journal of Infectious Diseases,
96, 73-81.
https://doi.org/10.1016/j.ijid.2020.02.026
Simonsen, A. T., Bill, M., Rosenberg, C. A., Hansen, M. H., Møller, P. L., Kjeldsen, E., Johansen, K. D.
, Ommen, H. B., Nederby, L.
, Aggerholm, A., Hokland, P. & Ludvigsen, M. (2020).
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
Leukemia Research,
92, Article 106350.
https://doi.org/10.1016/j.leukres.2020.106350
Clausen, M. R.
, Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M.
& d'Amore, F. (2019).
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
Leukemia and Lymphoma,
60(8), 1950-1957.
https://doi.org/10.1080/10428194.2018.1554863
Bro, M. L., Johansen, C.
, Vuust, P., Enggaard, L., Himmelstrup, B., Mourits-Andersen, T., Brown, P.
, d'Amore, F., Andersen, E. A. W., Abildgaard, N. & Gram, J. (2019).
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
27(10), 3887-3896.
https://doi.org/10.1007/s00520-019-04666-8
Pedersen, M. A.
, Gormsen, L. C., Kamper, P., Wassberg, C., Andersen, M. D., d'Amore, A. L., Barrington, S. F., Johnson, P.
, Hamilton-Dutoit, S., Amini, R. M., Enblad, G., Molin, D.
& d'Amore, F. (2019).
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
British Journal of Haematology,
186(3), 431-439.
https://doi.org/10.1111/bjh.15933